Drugs / UCLM802
Trials 2
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT05848999 | Apr 2023 → May 2025 | cancer or benign tumor | Zhejiang University | Unknown | No outcome recorded |
| Phase 1 | NCT05775666 | Mar 2023 → May 2024 | cancer | Peking University | Unknown | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | UCLM802 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05848999 ↗ |